Shown here amid red blood cells, hematopoietic stem cells (center) give rise to the cells of the bloodstream http://bit.ly/1HF8OSN
Hematologic malignancies are conditions where the bone marrow is damaged and the body stops to produce normal blood cells, and this calls for a need for allogenic hematopoetic cell transplant (allo-HCT). It is a curative used wherein stem cells from a donor, whose immune system is closely matched to the recipient are transplanted so that body starts producing blood normally. Graft-versus-host disease (GVHD) still remains a main challenge to allo-HCT, reasons being an increased amount of CD3⁺ T lymphocytes in the donor allograft, which causes a delay in the engraftment time, making way for increased risk for disease relapse and opportunistic infections.
A team of health researchers from the University of Florida by teams led by Grant McFadden and Christopher R. Cogle have discovered an ex vivo virtherapy with the oncolytic…
View original post 355 more words